Status:
NOT_YET_RECRUITING
Parenting and CAH - 21-hydroxylase Deficiency
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
CAH - 21-Hydroxylase Deficiency
Eligibility:
FEMALE
18+ years
Brief Summary
Congenital adrenal hyperplasia (CAH) is a genetic disease with autosomal recessive transmission, which is defined by a deficiency of one of the steroidogenesis enzymes. 21-hydroxylase deficiency (21OH...
Eligibility Criteria
Inclusion
- Patients aged 18 or over
- Patients with HCS due to 21-hydroxylase deficiency, confirmed genetically
- Patients who have been informed and do not object to participating in the research
Exclusion
- Patients who do not speak French
- Patients who are not affiliated to a social security scheme or who are not entitled to it
- Patients under legal protection, or under guardianship or trusteeship.
Key Trial Info
Start Date :
December 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06900153
Start Date
December 1 2025
End Date
December 1 2026
Last Update
November 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.